Source: UNIVERSITY OF CALIFORNIA, DAVIS submitted to NRP
IODIDE SUPPLEMENTATION AS A STRATEGY FOR ENHANCING BOVINE INNATE AIRWAY DEFENSES
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1005931
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Mar 2, 2015
Project End Date
Sep 30, 2015
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIVERSITY OF CALIFORNIA, DAVIS
410 MRAK HALL
DAVIS,CA 95616-8671
Performing Department
Medicine & Epidemology
Non Technical Summary
Bovine respiratory disease is an important cause of economic loss in the beef industry accounting for 31% of mortality in calves three weeks of age or older. Production losses of 10-25% are possible in cattle that developed BRD on a stocker operation. Vaccination programs have reduced BRD in postweaning cattle; however, many cattle are marketed each year without the benefit of such management. Consequently, beef producers rely heavily on antimicrobial drugs and have no useful options to control viral infections. Due to ever increasing scrutiny of antimicrobial usage in food producing animals and the threat of bacterial resistance to antimicrobials, it is important to investigate alternative strategies for bolstering the innate immune response and investigate compounds to treat or possibly prevent infectious diseases, especially compounds which are already approved for use in food producing animals such as sodium iodide. Iodide has been shown, in human studies, to enhance anti-viral and anti-bacterial activity of normal respiratory defense mechanisms. If these same mechanisms are effective against bovine pathogens, this system could be used as a preventative strategy against respiratory disease in cattle, and potentially reduce the need for antibiotics in feed producing animals. Results from this study are critical for determining if sodium iodide should be pursued as a preventive for respiratory disease in cattle, and will be used to apply for USDA funding for a larger scale study in a feedlot setting.
Animal Health Component
(N/A)
Research Effort Categories
Basic
100%
Applied
(N/A)
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31133101090100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3310 - Beef cattle, live animal;

Field Of Science
1090 - Immunology;
Goals / Objectives
Bovine respiratory disease is an important cause of economic loss in the beef industry accounting for 31% of mortality in calves three weeks of age or older. Production losses of 10-25% are possible in cattle that developed BRD on a stocker operation. Vaccination programs have reduced BRD in postweaning cattle; however, many cattle are marketed each year without the benefit of such management. Consequently, beef producers rely heavily on antimicrobial drugs and have no useful options to control viral infections. Due to ever increasing scrutiny of antimicrobial usage in food producing animals and the threat of bacterial resistance to antimicrobials, it is important to investigate alternative strategies for bolstering the innate immune response and investigate compounds to treat or possibly prevent infectious diseases, especially compounds which are already approved for use in food producing animals such as sodium iodideInnate airway defenses are crucial to preserving the health of bovine lungs. Stress coupled with viral infections compromise natural host defenses and allow bacteria to reach the lower airways and cause pneumonia. Ciliated epithelium in airways acts in concert with mucus to trap and physically remove pathogens from the respiratory tract and secreted antimicrobial peptides neutralize pathogens. An additional mechanism of innate airway protection composed of lactoperoxidase (LPO), hydrogen peroxide (H2O2), and halide ions has been recently described. Airway epithelium from several species, including cattle, can produce H2O2, by means of the dual oxygenase enzyme system, and excrete LPO from airway submucosal glands [3]. Cultured bovine tracheal explants are able to inactivate Staphylococcus aureus and Pseudomonas aeruginosa when supplemented with thiocyanate, a pseudohalide ion. Recently, it has been demonstrated that substituting thiocynate with iodide had profound in vitro antiviral activity against human respiratory syncytial virus and adenovirus. This study also demonstrated that oral administration of iodine in humans increased iodine concentrations on respiratory epithelial surfaces to levels comparable to those used in vitro. The LPO/H2O2/iodine system could be a powerful preventative strategy to augment innate airway defenses and prevent airway acquired infections.Two critical knowledge gaps currently exist. First, it is not currently known if important bovine pathogens are susceptible to inactivation by the LPO/H2O2/iodine system that is present in bovine airways. Second, it is not currently known to what extent cattle excrete iodide into airway fluid to enable the LPO/H2O2/iodine system. The purpose of the research proposed in this application is to determine the susceptibility of bovine pathogens to the LPO/H2O2/iodine system and to evaluate the kinetics of iodine in airway fluid following oral supplementation of cattle with different forms of iodine.Specific aim 1: Determine the direct effect of LPO/iodine system against bovine viral and bacterial pathogens: BHV-1,PI3, Truperella pyogenes (Tp), Manheimia hemolytica (Mh), Pasturella multocida (Pm), Histophilus somni.Specific aim 2: Determine the ability to increase concentration of iodide in respiratory secretions via oral NaI administration in cattle.
Project Methods
Specific aim 1: To determine the in vitro susceptibility of the bacterial pathogens (Tp, Mh, Pm, and Hs) and viral pathogens (BHV-1, and PI3) to inactivation by the LPO/H2O2/iodine system, hypoiodous acid (HOI), the functional antimicrobial molecule, will be generated in vitro using bovine milk derived LPO (Sigma, catalog number L2005), sodium iodide and H2O2. Bacterial isolates purchased from ATCC (Manassas, VA) will be inoculated into appropriate media and grown to log phase growth. Optical density readings will be used to calculate colony forming units, and standardized concentrations of each bacterial will be exposed to HOI by adding LPO and iodine to the media. Varying concentrations of NaI, ranging from 10- 250mM, and appropriate controls will be run in parallel. To determine the kinetics of bacterial inactivation, subsamples will be removed at 30 minutes, 1 hour and 3 hours and quantified by optical density reading and verified by standard plate counts on brain heart infusion agar using 10 fold serial dilutions. All experiments will be performed in triplicate. These experiments will be carried out by Dr. Heller. Similar experiments will be carried out by Dr. Newcomer to determine the susceptibility of BHV and PI3 in vitro. Based on the pilot study, viral inhibition in media will be checked at 5 minutes and 1 hour after the generation of the reaction. Dr. Newcomer will also carry out experiments in cell culture to define the effect of HOI on viral growth curve. Specific aim 2: To determine the kinetics of iodine in airway fluids of cattle after administration via rumen cannula, six 1-2 year old beef steers with previously placed rumen cannulas will be used. This sample size was chosen as the smallest valid sample size possible to attain variance estimates. The steers will be separated into two groups and will have baseline airway fluid samples collected prior receiving a single dose of 60mg/kg or 30mg/kg NaI via rumen cannula. 60mg/kg is the recommended dose for treatment of Actinomyces bovis infection[7]. NaI is approved for use in cattle. Serial samples of pharyngeal secretions will be collected using a flared pipette and suction at various timepoints until 48 hours post administration, blood will also be collected at each time point. Samples will be stored at -80°C until evaluated for iodine content by the Michigan State University Diagnostic Center for Population and Animal Health. Peak concentration and half-life of iodine in airway fluid will be determined. Animals will also be monitored for any adverse effects of iodide administration including signs of iodine toxicity. Anticipated results: Based on our preliminary results and results from human studies, we expect to achieve significant bacterial and viral inactivation by 30 minutes post reaction starting at concentrations of NaI at 10mM. We expect measureable and significant increase in airway fluid iodide concentration following single oral dose of either NaI or KI in healthy cattle. Analysis: Results for in-vitro studies will be analysed by repeated measures ANOVA, using Prism GraphPad software, comparing the effect of differing levels of NaI for each assay. Posthoc testing will be performed when significant results are found, significance will be set at p values less than or equal to 0.5. If data is not normally distributed a non-parametric test will be used. Results from the live animal study will be analyzed by SAS repeated measures analysis using a mixed model to determine area under the curve and peak concentrations.

Progress 03/02/15 to 09/30/15

Outputs
Target Audience:Results presented at Conference for Research Workers in Animal Disease and Americal College of Veterinary Internal Medicine annual meetings to international audiences. Results also reported in published manuscript in Journal of Veterinary Internal Medicine. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Project served as a resident research project for a large animal internal medicine resident, and provided experience in research study design and implementation as well as public presentation of results. How have the results been disseminated to communities of interest?Via presentations at veterinary conferences and publication in peer reviewed literature. What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Specific aim 1 was completed for the following pathogens: Bovine herpes virus-1, Parainfluenza virus-3, Bovine viral diarrheal virus, Manheimia hemolytica, Bibersteinia trehalosi. Specific aim 2 was completed.

Publications

  • Type: Journal Articles Status: Published Year Published: 2018 Citation: J Vet Intern Med. 2018 Jan;32(1):516-524. doi: 10.1111/jvim.14903. Efficacy of Oral Administration of Sodium Iodide to Prevent Bovine Respiratory Disease Complex. Shoemake BM1, Vander Ley BL2, Newcomer BW3, Heller MC4. Author information 1 College of Veterinary Medicine, University of Missouri, Columbia, MO. 2 Great Plains Veterinary Educational Center, University of Nebraska-Lincoln, Clay Center, NE. 3 Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL. 4 Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA. Abstract BACKGROUND: The prevention of bovine respiratory disease complex (BRD) in beef cattle is important to maintaining health and productivity of calves in feeding operations. OBJECTIVE: Determine whether BRD bacterial and viral pathogens are susceptible to the lactoperoxidase/hydrogen peroxide/iodide (LPO/H2 O2 /I- ) system in vitro and to determine whether the oral administration of sodium iodide (NaI) could achieve sufficient concentrations of iodine (I) in the respiratory secretions of weaned beef calves to inactivate these pathogens in vivo. ANIMALS: Sixteen weaned, apparently healthy, commercial beef calves from the University of Missouri, College of Veterinary Medicine teaching herd. METHODS: In vitro viral and bacterial assays were performed to determine susceptibility to the LPO/H2 O2 /I- system at varying concentrations of NaI. Sixteen randomly selected, healthy crossbred beef weanlings were administered 70 mg/kg NaI, or water, orally in a blinded, placebo-controlled trial. Blood and nasal secretions were collected for 72 hours and analyzed for I- concentration. RESULTS: Bovine herpesvirus-1, parainfluenza-3, Mannheimia haemolytica and Bibersteinia trehalosi were all inactivated or inhibited in vitro by the LPO/H2 O2 /I- reaction. Oral administration of NaI caused a marked increase in nasal fluid I concentration with a Cmax = 181 (1,420 ?M I), T12 , a sufficient concentration to inactivate these pathogens in vitro. CONCLUSIONS AND CLINICAL IMPORTANCE: In vitro, the LPO/H2 O2 /I- system inactivates and inhibits common pathogens associated with BRD. The administration of oral NaI significantly increases the I concentration of nasal fluid indicating that this system might be useful in preventing bovine respiratory infections. Copyright � 2018 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.


Progress 03/02/15 to 09/30/15

Outputs
Target Audience:Three separate abstracts have been submitted for the Annual Conference of Research Workers in Animal Disease (CRWAD), December 6-8, 2015, in Chicago, IL. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Specific Aim 2 was completed as a portion of research required for completeion of a masters degree by Dr Brian Shoemake, a large animal internal medicine resident and masters degree candidate at the University of Missouri. How have the results been disseminated to communities of interest?These results will be presented at the Annual Conference for Research Workers in Animal Disease (CRWAD), to be held December 6-8 in Chicago IL. This conference attracts many of the cutting edge researchers in bovine respiratory disease. What do you plan to do during the next reporting period to accomplish the goals?Publication of results in a scientific journal, journal and number of publications that will emerge from this work are yet to be determined.

Impacts
What was accomplished under these goals? Specific Aim 1 Respiratory viruses The in vitro susceptibility of parainfluenza 3 virus (PI3), bovine herpesvirus-1 (BoHV1), and bovine viral diarrhea virus (BVDV) to the LPO/H2O2/iodine system were determined. Stock cultures of each virus were incubated with LPO, H2O2, and sodium iodide at a concentration of 0, 10, 100, or 250 µM for 5, 15 or 60 minutes. Each assay was repeated in triplicate. Virus titration was performed by direct visualization of cytopathic effect in cultured cells. A dose-dependent decrease in viral concentration was observed for PI3, with decreased concentrations seen in all samples at even the lowest concentration of iodine included. For BoHV1, significant reduction in viral titer was seen at 100 µM iodine concentration. Of the 3 viruses, BVDV showed the least susceptibility to the system with no decrease in titer observed at even the highest concentrations of iodine. Titers were not affected by incubation time. This study indicates the LPO/H2O2/iodine system may hold value in the prevention of respiratory viral infection and the subsequent risk of BRDC. Bacteria Manheimia hemolytica and Bibersteinia trehalosi (formerly M. hemolytica biotype T), are susceptible to inactivation by the LPO/H2O2/halide system that is present in bovine airways. The susceptibility of these pathogens to inactivation by hypoiodous acid was determined by generating HOI in vitro using LPO, sodium iodide (NaI) and H2O2. Concentrations of NaI from 25 μM to 250 μM were tested, and controls were run in parallel. Subsamples were removed prior to addition of H2O2(catalyst) and at 5 and 30 minutes. Bacterial killing was assessed via standard plate counts. At all concentrations of NaI, both M. hemolytica and B. trehalosi were killed immediately by the complete reaction. Surprisingly, NaI alone at higher concentrations (above 50uM) inactivated both pathogens in vitro. NaI shows exciting promise as a preventative strategy for bovine respiratory disease which may also reduce antimicrobial use in food producing animals. Specific Aim 2 Oral administration of NaI to cattle resulted in increased levels of NaI in nasal secretions. A single dose of NaI resulted in NaI concentrations of over 100uM at 72 hours post administation. This is in excess of the NaI concentration necessary to inactivate the above respiratory viruses and bacteria in vitro.

Publications

  • Type: Conference Papers and Presentations Status: Submitted Year Published: 2015 Citation: In vitro inactivation of bovine viral respiratory pathogens using an iodine-based antimicrobial system B.W. Newcomer1*, B.L. Vander Ley2, P. K. Galik1, M.C. Heller3. 1Dept. of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL. 2Dept. of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO. 3Dept. of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA. Proceedings, Conference for Research Workers in Animal Disease, Dec 6-9, Chicago IL. Sodium iodide inactivates Manheimia hemolytica and Bibersteinia trehalosi in vitro. M.C. Heller1, K.A. Clothier2, B.W. Newcomer3, B.L. VanderLey4; 1Veterinary Medicine and Epidemiology, University of California Davis, Davis, CA, USA, 2California Animal Health and Food Safety Laboratory, University of California Davis, Davis, CA, USA, 3Department of Pathobiology, Auburn University, Auburn, AL, USA, 4Veterinary Medicine and Surgery, University of Missouri, Columbia, MO, USA. Proceedings, Conference for Research Workers in Animal Disease, Dec 6-9, Chicago IL. Iodine secretion in airway surface fluid following a single oral bolus of sodium iodide in calves. B.M. Shoemake1, B.L. Vander Ley1, M.A. Klingenberg1, R.A. Nolan1, A.M. Meyer2, L.G. Schultz1, B.W. Newcomer3, M.C. Heller4; 1College of Veterinary Medicine, University of Missouri, Columbia, MO, USA,2Department of Animal Sciences, College of Agriculture, Food and Natural Resources, University of Missouri, Columbia, MO, USA, 3Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA, 4Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, CA, USA. Proceedings, Conference for Research Workers in Animal Disease, Dec 6-9, Chicago IL.